Andrew Davis - May 20, 2024 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role: SVP, Chief Business Officer
Signature: /s/ Brian Tessler, Attorney-in-Fact
Stock symbol: IRWD
Transactions as of: May 20, 2024
Transactions value $: -$146,576
Form type: 4
Date filed: 5/22/2024, 04:05 PM
Previous filing: Mar 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRWD	Class A Common Stock	Sale	-$147K	-22.7K	-7.31%	$6.45	288K	May 20, 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Content

The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units and performance-based restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.